CXCL13 antibody for the treatment of autoimmune disorders. - Wikidata - wikimedia - TriplyDB

CXCL13 antibody for the treatment of autoimmune disorders.

CXCL13 antibody for the treatment of autoimmune disorders.

http://www.wikidata.org/entity/Q35086918

about

Translational utility of experimental autoimmune encephalomyelitis: recent developments Potential of Cells and Cytokines/Chemokines to Regulate Tertiary Lymphoid Structures in Human Diseases Development and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the Colon The Immunogenetics of Autoimmune Cholestasis Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission Regulated Production of CXCL13 within the Central Nervous System.The curious origins of angioimmunoblastic T-cell lymphoma Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis Targeting CXCL13 During Neuroinflammation CXCL13 is a plasma biomarker of germinal center activity.Circulating T follicular helper cells with increased function during chronic graft-versus-host disease Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.Association of Serum CXCL13 with Intrarenal Ectopic Lymphoid Tissue Formation in Lupus Nephritis.Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.T cell specific Cxcr5 deficiency prevents rheumatoid arthritis.B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model.The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis

P2860

Q26775820-A8B69D12-E7B5-4E19-AE31-C01A27481C40 Q28071670-F1C7A481-4971-4383-835D-0E55EAF276D1 Q28071695-180637CD-FD08-4789-8D71-AB8DF465D340 Q28085346-1B71B430-D2C2-4FFA-AB77-2DD5D26DD682 Q33562130-03B314CC-A52F-4141-AC55-670FBF6EDCC0 Q33772300-95A16FB1-5EFB-4C56-B652-C4E9C8393CE7 Q33877993-46BA9046-65BC-490C-968D-DA50C0AD22E0 Q36117017-AF90C6FF-E7CE-4862-9045-19A5F8B5B3A6 Q36551188-E5BBCFD8-149C-4C93-AB56-B4F11ECFA041 Q36684710-F7811B8C-968E-484D-A2F7-50B3B55834BA Q36920466-479DA927-6C78-40EF-A10F-F209FB6E7E0B Q36946564-726E949F-21FD-4592-B19F-D14793198A59 Q37470883-3977E2AB-0DFA-480A-8519-242E0C19CE7B Q37501812-9A24E5B9-FB67-4EA9-82AF-2B68CF7FC59A Q38615369-51C91ACC-B69D-47EC-885C-451CD30314A3 Q38688669-E7160AC3-D081-43E5-8404-6D6EBB915646 Q38728631-CCCBF773-0973-4644-9A91-7916F4A24201 Q38810926-EC1253E9-033A-4769-95B8-875C379FB4B1 Q38837294-59505995-06F8-4CE6-BFE1-4CF8D19139CE Q39108730-22F48740-668C-4820-BFE7-F5DC3BEE91D5 Q40229229-65CBFB26-2B5E-43D0-8F7B-9444BBF75CF2 Q47581475-81E13CBF-BBD4-4A9D-9259-C9A702F9A438 Q55052878-E4045E35-AAB4-4758-9113-2DDDDC02B03E Q57825780-DD99E868-4533-44BE-9AB5-4FD1634F8AD1 Q58803309-10A6AAEE-D2B2-4BF6-B564-A55506A45912

P2860

CXCL13 antibody for the treatment of autoimmune disorders.

http://www.wikidata.org/entity/Q35086918

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

CXCL13 antibody for the treatment of autoimmune disorders.

@ast

CXCL13 antibody for the treatment of autoimmune disorders.

@en

type

label

CXCL13 antibody for the treatment of autoimmune disorders.

@ast

CXCL13 antibody for the treatment of autoimmune disorders.

@en

prefLabel

CXCL13 antibody for the treatment of autoimmune disorders.

@ast

CXCL13 antibody for the treatment of autoimmune disorders.

@en

P1433

Q35086918-5393AA69-9CB5-4313-AFF6-EF83F6623095

P1476

Q35086918-56F5EC93-EEF2-4D01-B7BD-0347BE59E3C4

P2093

Q35086918-186F3CEF-087E-47CF-A473-D6E5CDC8CEAC

Q35086918-26078116-7837-4B87-B8CF-79EED6E8F86C

Q35086918-2BB31AD8-D51E-4B28-8A71-70296E956529

Q35086918-38AD7826-532E-448A-A437-0CF8DA9A6102

Q35086918-5E511C6C-FCDC-47AE-9F57-26DB8EE62F2E

Q35086918-69D70B7B-9201-4829-A114-5087C32D6E5B

Q35086918-881C8D80-3C7D-4130-8C51-BFBC5B03A914

Q35086918-8C1CC93F-E913-4D14-AEB8-1963C539A377

Q35086918-B83339A6-B23A-49FE-85D4-57EA130AA728

Q35086918-C49AFE86-B9A3-4DF3-9C97-D61868BBD83B

P2860

Q35086918-00682A4B-2FEB-4FBF-8399-CD3773A3796E

Q35086918-02DF4606-D939-4F5F-B99D-1EE171384D7E

Q35086918-0CED1769-6338-41EC-936A-52625D84E858

Q35086918-12414F68-7F6E-49B8-AE8B-812A8EFE2704

Q35086918-2235DDC8-7E5D-4F1C-A0DF-6B70B926D8F8

Q35086918-223D2833-F432-4FF4-A007-55CDF44A4090

Q35086918-28C4EBE4-0E14-481B-A273-56BAE4101EE8

Q35086918-2CEFA7AC-34EB-402C-B947-AE4EC08ACE44

Q35086918-3054C184-70F5-4F5A-86C5-36C82C8D61E0

Q35086918-313C8618-B69F-47DB-AFE6-BC500A6AE538

P2888

Q35086918-86D9B89A-9F4C-4295-B3EB-0D1847CE92FB

P304

Q35086918-D79B210E-D8CD-4CF2-83BF-78315DCAC689

P31

Q35086918-7E53AD63-9AAB-46B7-949E-154DF62F73DE

P356

Q35086918-06F602A6-1F27-4490-B1E3-44B47ECFDD9F

P478

Q35086918-B031D4B5-5ADB-45F7-A760-5E14EF1004B8

P577

Q35086918-8F815F09-876A-46BA-8893-CABC414E37C7

P5875

Q35086918-EAB176A0-7876-4102-8F98-B8B758C611D1

P6179

Q35086918-4CB68F54-5B95-40E0-92B6-4E2CC361095B

P698

Q35086918-96564BCE-1DF5-4F32-A89A-AE46A2A381AD

P932

Q35086918-7D7C2DC3-B6FB-4817-98C4-D590CE66CE76

P356

S12865-015-0068-1

P1433

P1476

CXCL13 antibody for the treatment of autoimmune disorders.

@en

P2093

Alan Jonason

http://www.w3.org/2001/XMLSchema#string

Christine Reilly

http://www.w3.org/2001/XMLSchema#string

Crystal Mallow

http://www.w3.org/2001/XMLSchema#string

Ekaterina Klimatcheva

http://www.w3.org/2001/XMLSchema#string

Ernest S Smith

http://www.w3.org/2001/XMLSchema#string

Holm Bussler

http://www.w3.org/2001/XMLSchema#string

Maria Scrivens

http://www.w3.org/2001/XMLSchema#string

Mark Paris

http://www.w3.org/2001/XMLSchema#string

Maurice Zauderer

http://www.w3.org/2001/XMLSchema#string

Michael Doherty

http://www.w3.org/2001/XMLSchema#string

P2860

Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor

Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis

The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia

Follicular helper T cells: lineage and location

Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus

Th17 effector cells support B cell responses outside of germinal centres

A chemokine-driven positive feedback loop organizes lymphoid follicles

P2888

s12865-015-0068-1

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12865-015-0068-1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275051986

http://www.w3.org/2001/XMLSchema#string

P6179

1018978976

http://www.w3.org/2001/XMLSchema#string

P698

25879435

http://www.w3.org/2001/XMLSchema#string

P932

4329654

http://www.w3.org/2001/XMLSchema#string